Antiretroviral Drugs

Disgrifiad caffael

Supply of Antiretroviral Drugs which are all shortly due to lose their patent exclusivity (or have previously lost their exclusivity) and therefore will have competition available in the UK.

Prif gategori

Nwyddau

Rhanbarthau cyflawni

• UKL - Wales

Cyfanswm gwerth (amcangyfrif)

1512963.00 GBP Heb gynnwys TAW

1815556.00 GBP Gan gynnwys TAW

Dyddiadau contract (amcangyfrif)

01 Ebrill 2027, 00:00yb to 30 Mehefin 2028, 23:59yh

Dyddiad gorffen yr estyniad (os defnyddir yr holl estyniadau): 30 Mehefin 2029

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

A yw cyfanswm y gwerth uwchlaw'r trothwy?

Uwchben y trothwy

Dosbarthiadau CPV

• 33600000 - Cynhyrchion fferyllol

Rhanbarthau cyflawni

• UKL - Wales

Cynaladwyedd

Busnesau bach a chanolig (BBaCh)

Mentrau gwirfoddol, cymunedol a chymdeithasol (VCSE)

Dyddiad cychwyn y contract (amcangyfrif)

01 Ebrill 2027, 00:00yb

Dyddiad diwedd y contract (amcangyfrif)

30 Mehefin 2028, 23:59yh

Dyddiad gorffen yr estyniad (amcangyfrif)

30 Mehefin 2029, 23:59yh

A ellir ymestyn y contract?

Oes

Disgrifiad o'r broses ymgysylltu

This notice is being issued to advise suppliers of a forthcoming opportunity that is due to be published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts).

This contract is for Antiretroviral Drugs which are all shortly due to lose their patent exclusivity (or have previously lost their exclusivity) and therefore will have competition available in the UK.

There is no formal engagement process for this opportunity.

Any suppliers who may like more information on this opportunity before the tender is published please contact Rachelle Elvin (rachelle.elvin@wales.nhs.uk).

Dyddiad dyledus

06 Tachwedd 2026, 23:59yh

A yw’r cyfnod ymgysylltu eisoes wedi dod i ben?

Nac ydw

Dyddiad cyhoeddi hysbysiad tendro (amcangyfrif)

30 Tachwedd 2026